Nihon Kohden (OTCMKTS:NHNKY) Trading 7.9% Higher – Time to Buy?

Shares of Nihon Kohden Corporation (OTCMKTS:NHNKY) shot up 7.9% on Monday . The company traded as high as $9.44 and last traded at $9.40. 2,946 shares changed hands during trading, a decline of 90% from the average session volume of 29,891 shares. The stock had previously closed at $8.71.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised shares of Nihon Kohden to a “hold” rating in a report on Monday, April 27th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, Nihon Kohden presently has a consensus rating of “Buy”.

Nihon Kohden Price Performance

The company has a fifty day moving average of $9.42 and a two-hundred day moving average of $10.46. The stock has a market capitalization of $1.62 billion, a P/E ratio of 16.03 and a beta of 0.41.

Nihon Kohden (OTCMKTS:NHNKY) last released its earnings results on Thursday, May 14th. The company reported $0.34 EPS for the quarter, topping analysts’ consensus estimates of $0.24 by $0.10. Nihon Kohden had a return on equity of 9.48% and a net margin of 6.08%.The company had revenue of $453.10 million for the quarter, compared to the consensus estimate of $414.40 million. As a group, equities research analysts predict that Nihon Kohden Corporation will post 0.61 EPS for the current fiscal year.

Nihon Kohden Company Profile

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.